ABOUT CASSS MEETINGS
CASSS meetings bring together industry, regulatory, and academic professionals for critical discussions to solve technical and regulatory challenges in the field of biopharmaceutical development. CASSS Symposia and Fora provide venues for biopharmaceutical professionals to:
- Connect with a relevant global network.
- Gain tangible knowledge for career advancement.
- Learn best practices from prominent contributors in the industry.
-
Symposium on mRNA
May 29 to 30, 2025The NEW Symposium on mRNA explores how mRNA has become a new modality and how mRNA vaccines are applied.
-
CGTP Summit
June 9, 2025This one-day Summit is designed to discuss pertinent challenges in the cell and gene therapy field through speaker presentations with interactive, in-depth panel discussions.
-
Cell and Gene Therapy Products
June 10 to 12, 2025The Symposium will bring together industry, regulatory, and academic professionals to discuss pertinent challenges in the cell and gene therapy field.
-
DC Discussion Group
June 17, 2025The DC Discussion Group allows you to network in-person with DC-area CASSS members.
-
Consultants' Network
June 23, 2025The purpose of the CASSS Consultants' Network is to facilitate discussions among consultants.
-
CMC Strategy Forum North America
July 14 to 15, 2025The purpose of the CMC Strategy Forum is to provide a venue for biotechnology/biological product discussion on relevant CMC issues throughout the lifecycle of a product.
-
CMC Strategy Forum Latin America Session I
August 13, 2025The Latin America Forum explores a number of critical topics focused on improving the quality in development and manufacturing of biopharmaceutical products.
-
CMC Strategy Forum Latin America Session II
August 20, 2025
The Latin America Forum explores a number of critical topics focused on improving the quality in development and manufacturing of biopharmaceutical products.
-
CE Pharm
September 7 to 10, 2025The Symposium discusses recent developments in capillary electrophoresis (CE) analysis of protein, nucleotide, and small molecule pharmaceuticals.
-
Mass Spectrometry
September 23 to 26, 2025The focus of this Symposium is the practical application of mass spectrometry (MS) in the biotechnology industry.
-
CMC Strategy Forum Europe
October 20 to 22, 2025Adhering to the established CMC Forum series model, the Forum highlights topics and regulatory updates pertinent to Europe.
-
Cell and Gene Therapy Products Europe
October 23 to 24, 2025The NEW Symposium will bring together industry, regulatory, and academic professionals to discuss specific European issues related to CGTP while maintaining a global outlook.
-
CMC Strategy Forum Japan
December 8 to 9, 2025Adhering to the established CMC Forum series model, the Forum highlights topics and regulatory updates pertinent to Japan and the Asia/Pacific Region.
-
CMC Strategy Forum North America
January 26, 2026
The purpose of the CMC Strategy Forum is to provide a venue for biotechnology/biological product discussion on relevant CMC issues throughout the lifecycle of a product.
-
WCBP
January 27 to 29, 2026The WCBP Symposium addresses the role of current and emerging CMC analytical technology among evolving US and international regulatory perspectives.
-
Bioassays
April 27 to 29, 2026The CASSS Bioassays Symposium presents an opportunity to discuss current perspectives, strategies, and technologies used for bioassays.
Fast Facts
- Annually, CASSS holds 15 scientific, multi-day Symposia, Fora, and Discussion Groups around the world.
- Attendees represent 30 regulatory agencies and 440 biopharmaceutical companies.
- Members reside in 46 countries throughout North America, Europe, Asia, Africa, and South America.
Code of Conduct
CASSS is committed to providing a safe, productive, and welcoming environment for all meeting participants and CASSS staff. All participants, including, but not limited to, attendees, speakers, volunteers, industry, partners, exhibitors, CASSS staff members, service providers, and all others are expected to abide by this Code of Conduct.